Humatrope 72iu (24mg)

Humatrope 72IU (24mg)

Humatrope 72IU (24mg) is a prescription human growth hormone medicine containing somatropin, a recombinant form of human growth hormone. This presentation provides 24 mg of somatropin, equivalent to 72 IU, in a single-patient-use cartridge. The cartridge is intended for subcutaneous administration after reconstitution and must be used with the corresponding HumatroPen 24 mg injection device.

Humatrope is manufactured by Lilly and is supplied as a sterile, white lyophilized powder. Somatropin is produced using recombinant DNA technology and has the same 191-amino-acid sequence as naturally occurring human pituitary growth hormone. Because this is an active prescription hormone, it should only be used when prescribed and supervised by a qualified healthcare professional.

General Information

Product name: Humatrope 72IU (24mg)
Manufacturer: Lilly, Turkey
Active substance: Somatropin (recombinant human growth hormone)
Strength: 24 mg / 72 IU
Dosage form: Lyophilized powder for solution for injection
Administration route: Subcutaneous injection after reconstitution
Pack: 1 single-patient-use 24 mg cartridge with diluent
Compatible device: HumatroPen 24 mg
Prescription status: Prescription medicine

Product Presentation

The 24 mg Humatrope cartridge is the highest-strength cartridge presentation listed in current prescribing information. Each cartridge contains 24 mg, equivalent to 72 IU, of somatropin and is designed specifically for use with the HumatroPen 24 mg device. The cartridge should not be used with a HumatroPen intended for a different strength.

The cartridge is supplied with diluent for reconstitution. Preparation, mixing, dose measurement, injection technique, and device handling should follow the official Instructions for Use and the directions provided by the prescribing healthcare professional. The product should not be shaken during preparation.

What Humatrope Contains

The active ingredient in Humatrope 72IU (24mg) is somatropin. According to the official prescribing information, the 24 mg cartridge also contains inactive ingredients including glycine, mannitol, and dibasic sodium phosphate. The accompanying diluent contains Water for Injection, metacresol as a preservative, and glycerin.

Patients with known sensitivity to any component of the medicine or diluent should discuss this with their healthcare professional before use. Packaging, labeling, batch information, and expiry details should always be checked before the cartridge is prepared.

Storage and Handling

Humatrope requires refrigerated storage. Unmixed and reconstituted cartridges should be stored at 2°C to 8°C (36°F to 46°F). The product should not be frozen and should remain protected from light in its original packaging. After reconstitution, the cartridge must be kept refrigerated and, according to current manufacturer instructions, used within 28 days.

Do not use a cartridge that has been frozen, is expired, has damaged packaging, or shows an unexpected change in appearance after preparation. Correct cold-chain handling is particularly important for biological medicines because inappropriate temperatures may affect product integrity.

Medical Use and Safety

Humatrope is used for specific medically diagnosed conditions involving growth hormone deficiency or certain growth disorders. Approved uses differ between pediatric and adult patients and must be determined by a healthcare professional. The appropriate dose is individualized and should not be selected from general online information.

Humatrope is not an ordinary nutritional, fitness, or bodybuilding supplement. Somatropin can affect glucose metabolism, fluid balance, thyroid function, and other physiological processes. It also has important contraindications and precautions, including certain critical illnesses, active malignancy, severe diabetic retinopathy, and specific pediatric circumstances described in the prescribing information.

Patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter products, and hormone therapies they use before starting treatment. Any unexpected reaction or change in health during treatment should be discussed promptly with a qualified medical professional.

Product Verification

Before use, confirm that the carton and cartridge clearly identify Humatrope, somatropin, the 24 mg strength, the correct HumatroPen compatibility, batch or lot information, and expiry date. The official Humatrope product information and Humatrope prescribing information are the best references for current formulation, storage, safety, and device details.

Humatrope 72IU (24mg) should be supplied, stored, prepared, and used as a prescription medicine, with professional medical guidance and appropriate refrigerated handling throughout the product lifecycle.